Expression and shedding of endothelial protein C receptor in prostate cancer cells
2011

Endothelial Protein C Receptor in Prostate Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Mario Menschikowski, Albert Hagelgans, Oliver Tiebel, Ludwig Klinsmann, Graeme Eisenhofer, Gabriele Siegert

Primary Institution: Institute of Clinical Chemistry and Laboratory Medicine, Technical University of Dresden

Hypothesis

The study aims to analyze the expression, cell surface exposition, and shedding of endothelial protein C receptor (EPCR) in normal and malignant prostate cell lines.

Conclusion

The study demonstrates significant differences in the expression and shedding of EPCR in prostate cancer cell lines compared to normal cells, which may be important for understanding its role in cancer.

Supporting Evidence

  • EPCR expression is higher in invasive prostate cancer cells compared to normal cells.
  • Pharmacological agents can induce the release of soluble EPCR in prostate cells.
  • IL-1β and TNF-α significantly increase sEPCR release in certain prostate cancer cell lines.

Takeaway

This study found that prostate cancer cells have more of a certain protein (EPCR) on their surface than normal cells, which might help the cancer grow.

Methodology

The study used flow cytometry, ELISA, and various pharmacological agents to analyze EPCR expression and shedding in prostate cell lines.

Limitations

The study primarily focuses on in vitro cell lines, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1475-2867-11-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication